Leukemia, Myelogenous, Chronic, BCR-ABL PositiveFusion Proteins, bcr-ablPyrimidinesBlast CrisisBenzamidesPiperazinesLeukemia, Myeloid, AcutePhiladelphia ChromosomeLeukemia, MyeloidK562 CellsLeukemiaLeukemia, Myeloid, Chronic-PhaseThiazolesLeukemia, Myeloid, Accelerated PhaseChromosomes, Human, 21-22 and YGenes, ablProto-Oncogene Proteins c-bcrProtein Kinase InhibitorsAntineoplastic AgentsLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeBone MarrowCytarabineBone Marrow TransplantationProtein-Tyrosine KinasesGene Expression Regulation, LeukemicDrug Resistance, NeoplasmProto-Oncogene Proteins c-ablHarringtoninesLeukemia, LymphoidInterferon-alphaKaryotypingHematopoietic Stem CellsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplastic Stem CellsLeukemia, ExperimentalGranulocytesTumor Cells, CulturedLeukemia, Lymphocytic, Chronic, B-CellCytogenetic AnalysisTransplantation, HomologousTranslocation, GeneticRNA, NeoplasmHydroxyureaDaunorubicinGraft vs Host DiseaseMyeloproliferative DisordersApoptosisBusulfanTumor Stem Cell AssayHL-60 CellsCytogeneticsMyelodysplastic SyndromesNeoplasm Proteinssrc-Family KinasesAntigens, CD34Chromosome AberrationsGraft vs Leukemia EffectTreatment OutcomeChromosomes, Human, Pair 22Cell Line, TumorNeoplasm, ResidualGene RearrangementAntineoplastic Combined Chemotherapy ProtocolsRecurrenceDNA NucleotidylexotransferaseHematopoietic Stem Cell TransplantationRNA, MessengerChromosomes, Human, Pair 9Cell Transformation, NeoplasticOncogenesAcute DiseaseBase SequenceOxazepinesDNA, NeoplasmCell DivisionBone Marrow CellsSurvival AnalysisPolymerase Chain ReactionThrombocytosisProto-Oncogene ProteinsMolecular Sequence DataCore Binding Factor Alpha 2 SubunitCell LineThioguanineDrug SynergismPrognosisSialic Acid Binding Ig-like Lectin 3Chromosomes, Human, Pair 21Blotting, SouthernArsenicalsSplenomegalyLymphocyte TransfusionColony-Forming Units AssayHematopoiesisPrimary MyelofibrosisClone CellsLeukemic InfiltrationMegakaryocytesLeukemia Virus, Murine